

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 6.54753531 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.50910517 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 6.50910517 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.27153180 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.27153180 |
| 6 | ethanol metabolic process (GO:0006067) | 5.98034841 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.94236395 |
| 8 | primary alcohol catabolic process (GO:0034310) | 5.77835802 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.73371097 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 5.44363896 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 5.44055346 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.44055346 |
| 13 | tryptophan catabolic process (GO:0006569) | 5.44055346 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.43284261 |
| 15 | negative regulation of fibrinolysis (GO:0051918) | 5.41605395 |
| 16 | kynurenine metabolic process (GO:0070189) | 5.38488506 |
| 17 | omega-hydroxylase P450 pathway (GO:0097267) | 5.35330903 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 5.20606794 |
| 19 | regulation of fibrinolysis (GO:0051917) | 5.15784585 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 5.15118104 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.14668933 |
| 22 | protein carboxylation (GO:0018214) | 5.14668933 |
| 23 | glyoxylate metabolic process (GO:0046487) | 5.12545538 |
| 24 | tryptophan metabolic process (GO:0006568) | 5.09564167 |
| 25 | regulation of protein activation cascade (GO:2000257) | 5.06053685 |
| 26 | urea metabolic process (GO:0019627) | 5.02475109 |
| 27 | urea cycle (GO:0000050) | 5.02475109 |
| 28 | complement activation, alternative pathway (GO:0006957) | 4.99984548 |
| 29 | cysteine metabolic process (GO:0006534) | 4.92081013 |
| 30 | daunorubicin metabolic process (GO:0044597) | 4.89006903 |
| 31 | polyketide metabolic process (GO:0030638) | 4.89006903 |
| 32 | doxorubicin metabolic process (GO:0044598) | 4.89006903 |
| 33 | cellular glucuronidation (GO:0052695) | 4.80994598 |
| 34 | regulation of complement activation (GO:0030449) | 4.79908507 |
| 35 | response to nitrosative stress (GO:0051409) | 4.72678113 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.68286116 |
| 37 | nitrogen cycle metabolic process (GO:0071941) | 4.60236335 |
| 38 | bile acid metabolic process (GO:0008206) | 4.55985466 |
| 39 | reverse cholesterol transport (GO:0043691) | 4.55646930 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 4.54620194 |
| 41 | uronic acid metabolic process (GO:0006063) | 4.41688263 |
| 42 | glucuronate metabolic process (GO:0019585) | 4.41688263 |
| 43 | xenobiotic catabolic process (GO:0042178) | 4.40582053 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.38661757 |
| 45 | benzene-containing compound metabolic process (GO:0042537) | 4.36873491 |
| 46 | phospholipid efflux (GO:0033700) | 4.34286529 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.34171598 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.34171598 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.34171598 |
| 50 | serine family amino acid catabolic process (GO:0009071) | 4.31451957 |
| 51 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.31001244 |
| 52 | aromatic amino acid family metabolic process (GO:0009072) | 4.28837059 |
| 53 | homocysteine metabolic process (GO:0050667) | 4.26352653 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 4.25186984 |
| 55 | regulation of apoptotic cell clearance (GO:2000425) | 4.23634453 |
| 56 | tyrosine metabolic process (GO:0006570) | 4.21564657 |
| 57 | drug metabolic process (GO:0017144) | 4.17718227 |
| 58 | plasma lipoprotein particle clearance (GO:0034381) | 4.16894955 |
| 59 | negative regulation of sterol transport (GO:0032372) | 4.16772936 |
| 60 | negative regulation of cholesterol transport (GO:0032375) | 4.16772936 |
| 61 | ethanol oxidation (GO:0006069) | 4.15420726 |
| 62 | triglyceride homeostasis (GO:0070328) | 4.13166547 |
| 63 | acylglycerol homeostasis (GO:0055090) | 4.13166547 |
| 64 | lysine catabolic process (GO:0006554) | 4.12426505 |
| 65 | lysine metabolic process (GO:0006553) | 4.12426505 |
| 66 | blood coagulation, intrinsic pathway (GO:0007597) | 4.08261706 |
| 67 | alpha-amino acid catabolic process (GO:1901606) | 3.98127564 |
| 68 | cholesterol efflux (GO:0033344) | 3.97137457 |
| 69 | fibrinolysis (GO:0042730) | 3.94518419 |
| 70 | bile acid and bile salt transport (GO:0015721) | 3.90412201 |
| 71 | coenzyme catabolic process (GO:0009109) | 3.81946754 |
| 72 | negative regulation of blood coagulation (GO:0030195) | 3.79344823 |
| 73 | negative regulation of hemostasis (GO:1900047) | 3.79344823 |
| 74 | regulation of cholesterol homeostasis (GO:2000188) | 3.78571257 |
| 75 | epoxygenase P450 pathway (GO:0019373) | 3.77254589 |
| 76 | cellular ketone body metabolic process (GO:0046950) | 3.76633091 |
| 77 | aldehyde catabolic process (GO:0046185) | 3.76053309 |
| 78 | indolalkylamine metabolic process (GO:0006586) | 3.75840636 |
| 79 | primary alcohol metabolic process (GO:0034308) | 3.71512299 |
| 80 | cellular amino acid catabolic process (GO:0009063) | 3.71429195 |
| 81 | axonemal dynein complex assembly (GO:0070286) | 3.70718680 |
| 82 | amine catabolic process (GO:0009310) | 3.70080295 |
| 83 | cellular biogenic amine catabolic process (GO:0042402) | 3.70080295 |
| 84 | negative regulation of lipase activity (GO:0060192) | 3.67160818 |
| 85 | cellular modified amino acid catabolic process (GO:0042219) | 3.66567975 |
| 86 | glutamate metabolic process (GO:0006536) | 3.65074414 |
| 87 | plasma lipoprotein particle assembly (GO:0034377) | 3.64091171 |
| 88 | regulation of humoral immune response (GO:0002920) | 3.62988873 |
| 89 | positive regulation of lipid catabolic process (GO:0050996) | 3.62169408 |
| 90 | imidazole-containing compound metabolic process (GO:0052803) | 3.60766669 |
| 91 | glycine metabolic process (GO:0006544) | 3.60008982 |
| 92 | low-density lipoprotein particle remodeling (GO:0034374) | 3.59757894 |
| 93 | phospholipid homeostasis (GO:0055091) | 3.57337610 |
| 94 | drug catabolic process (GO:0042737) | 3.55528265 |
| 95 | serine family amino acid metabolic process (GO:0009069) | 3.55110377 |
| 96 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.54182071 |
| 97 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.51086028 |
| 98 | complement activation, classical pathway (GO:0006958) | 3.51006382 |
| 99 | regulation of plasminogen activation (GO:0010755) | 3.49202128 |
| 100 | complement activation (GO:0006956) | 3.49118993 |
| 101 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.49049335 |
| 102 | progesterone metabolic process (GO:0042448) | 3.47753896 |
| 103 | negative regulation of coagulation (GO:0050819) | 3.47476631 |
| 104 | arginine metabolic process (GO:0006525) | 3.47275728 |
| 105 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.46376420 |
| 106 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.46376420 |
| 107 | cholesterol homeostasis (GO:0042632) | 3.46157465 |
| 108 | opsonization (GO:0008228) | 3.45278226 |
| 109 | phenylpropanoid metabolic process (GO:0009698) | 3.44240039 |
| 110 | negative regulation of protein activation cascade (GO:2000258) | 3.42972458 |
| 111 | intestinal cholesterol absorption (GO:0030299) | 3.42955228 |
| 112 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.42498240 |
| 113 | sterol homeostasis (GO:0055092) | 3.40886779 |
| 114 | cofactor catabolic process (GO:0051187) | 3.39800392 |
| 115 | protein activation cascade (GO:0072376) | 3.39395992 |
| 116 | acute-phase response (GO:0006953) | 3.38834678 |
| 117 | regulation of bile acid biosynthetic process (GO:0070857) | 3.38371269 |
| 118 | protein-lipid complex assembly (GO:0065005) | 3.36785244 |
| 119 | regulation of cholesterol metabolic process (GO:0090181) | 3.36608276 |
| 120 | positive regulation of hemostasis (GO:1900048) | 3.36350656 |
| 121 | positive regulation of blood coagulation (GO:0030194) | 3.36350656 |
| 122 | negative regulation of wound healing (GO:0061045) | 3.36292846 |
| 123 | lipoprotein metabolic process (GO:0042157) | 3.35777995 |
| 124 | flavonoid metabolic process (GO:0009812) | 3.32688889 |
| 125 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.20481229 |
| 126 | negative regulation of lipid transport (GO:0032369) | 3.19272617 |
| 127 | positive regulation of coagulation (GO:0050820) | 3.16489173 |
| 128 | response to mercury ion (GO:0046689) | 3.15709762 |
| 129 | negative regulation of humoral immune response (GO:0002921) | 3.13689748 |
| 130 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.09475276 |
| 131 | oxidative demethylation (GO:0070989) | 3.08217446 |
| 132 | positive regulation of extracellular matrix organization (GO:1903055) | 3.06343252 |
| 133 | negative regulation of complement activation (GO:0045916) | 2.95719646 |
| 134 | xenobiotic metabolic process (GO:0006805) | 2.91899942 |
| 135 | carnitine metabolic process (GO:0009437) | 2.91009034 |
| 136 | low-density lipoprotein particle clearance (GO:0034383) | 2.89836756 |
| 137 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.89509479 |
| 138 | androgen biosynthetic process (GO:0006702) | 2.88296573 |
| 139 | C21-steroid hormone metabolic process (GO:0008207) | 2.81964953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.20697401 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.25319440 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.73816799 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.65803806 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.89830933 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.43879590 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.95940165 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.67825300 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.95156526 |
| 10 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.38693040 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.35431038 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.31530462 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.18964153 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11479295 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.1616955 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.88680708 |
| 17 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.86708022 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.71144239 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.63475344 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58365895 |
| 21 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.53787409 |
| 22 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.50300812 |
| 23 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.44454238 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.43165957 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41790255 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38801437 |
| 27 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.38588189 |
| 28 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32427990 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.31122840 |
| 30 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30644372 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.28585646 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.25587389 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24386492 |
| 34 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.23906355 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.22464365 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.21324666 |
| 37 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.20681462 |
| 38 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.20681462 |
| 39 | KDM2B_26808549_Chip-Seq_K562_Human | 1.19040436 |
| 40 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18825280 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17550289 |
| 42 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.16864936 |
| 43 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.15159222 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13962036 |
| 45 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.13098457 |
| 46 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.11444895 |
| 47 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10906155 |
| 48 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.10765637 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09295176 |
| 50 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08256720 |
| 51 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08077502 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.07643640 |
| 53 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.07173796 |
| 54 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06620016 |
| 55 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05390425 |
| 56 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04634320 |
| 57 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.03294940 |
| 58 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02122213 |
| 59 | * P68_20966046_ChIP-Seq_HELA_Human | 1.00240016 |
| 60 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99893340 |
| 61 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99778085 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.97480732 |
| 63 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97020669 |
| 64 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96322248 |
| 65 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95348585 |
| 66 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.94694496 |
| 67 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93887520 |
| 68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92512677 |
| 69 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.92469562 |
| 70 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.92078285 |
| 71 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91574564 |
| 72 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91189884 |
| 73 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90739468 |
| 74 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.90329359 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.90174977 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.88327446 |
| 77 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.87887430 |
| 78 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.87204350 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.86792889 |
| 80 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.86562799 |
| 81 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.86395331 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86061026 |
| 83 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.85901116 |
| 84 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.85849613 |
| 85 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82874456 |
| 86 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.82830806 |
| 87 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.82136775 |
| 88 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.80610688 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78855048 |
| 90 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78488158 |
| 91 | CJUN_26792858_Chip-Seq_BT549_Human | 0.77817947 |
| 92 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73539059 |
| 93 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.72989483 |
| 94 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.72389171 |
| 95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.70419321 |
| 96 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.69058902 |
| 97 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.66854715 |
| 98 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.65501691 |
| 99 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.65411437 |
| 100 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.63152841 |
| 101 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.62958611 |
| 102 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62821105 |
| 103 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.62537723 |
| 104 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.61183063 |
| 105 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.61131433 |
| 106 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60657149 |
| 107 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.60148898 |
| 108 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.60079957 |
| 109 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.60079957 |
| 110 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.59769605 |
| 111 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.59582661 |
| 112 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58581256 |
| 113 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.58005842 |
| 114 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.57565131 |
| 115 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.57524034 |
| 116 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.56246100 |
| 117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.55581256 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.54847045 |
| 119 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.54707618 |
| 120 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54526302 |
| 121 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.53986543 |
| 122 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.53864957 |
| 123 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.53864957 |
| 124 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.53507943 |
| 125 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.53249608 |
| 126 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.52956893 |
| 127 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52778236 |
| 128 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.52397129 |
| 129 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.51390753 |
| 130 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.50809412 |
| 131 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.50475525 |
| 132 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.50183473 |
| 133 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.49876991 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.49829749 |
| 135 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.49735668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.52800815 |
| 2 | MP0005360_urolithiasis | 6.66472316 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.66258654 |
| 4 | MP0005365_abnormal_bile_salt | 5.56392239 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.03193592 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.85035461 |
| 7 | MP0003252_abnormal_bile_duct | 3.76803073 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.29306922 |
| 9 | MP0009840_abnormal_foam_cell | 3.19509507 |
| 10 | MP0005083_abnormal_biliary_tract | 2.76307192 |
| 11 | MP0005332_abnormal_amino_acid | 2.43924201 |
| 12 | MP0003195_calcinosis | 2.38916177 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.36427954 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.31788863 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.28368538 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.00407365 |
| 17 | MP0000609_abnormal_liver_physiology | 2.00093593 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 1.92604132 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.91008190 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.72122452 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 1.67381613 |
| 22 | MP0008438_abnormal_cutaneous_collagen | 1.60698131 |
| 23 | MP0002254_reproductive_system_inflammat | 1.56882137 |
| 24 | MP0010368_abnormal_lymphatic_system | 1.48828848 |
| 25 | MP0003868_abnormal_feces_composition | 1.48308539 |
| 26 | MP0003186_abnormal_redox_activity | 1.47846512 |
| 27 | MP0002132_abnormal_respiratory_system | 1.39660755 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.39232634 |
| 29 | MP0001764_abnormal_homeostasis | 1.29483026 |
| 30 | MP0009643_abnormal_urine_homeostasis | 1.27576529 |
| 31 | MP0002909_abnormal_adrenal_gland | 1.26578987 |
| 32 | MP0005375_adipose_tissue_phenotype | 1.19544055 |
| 33 | MP0003879_abnormal_hair_cell | 1.18826468 |
| 34 | MP0004858_abnormal_nervous_system | 1.17449062 |
| 35 | MP0003011_delayed_dark_adaptation | 1.12726331 |
| 36 | MP0009764_decreased_sensitivity_to | 1.10983392 |
| 37 | MP0000598_abnormal_liver_morphology | 1.10114864 |
| 38 | MP0000604_amyloidosis | 1.07265815 |
| 39 | MP0005275_abnormal_skin_tensile | 1.07018870 |
| 40 | MP0009697_abnormal_copulation | 1.06052434 |
| 41 | MP0004185_abnormal_adipocyte_glucose | 1.05113511 |
| 42 | MP0005451_abnormal_body_composition | 1.04912882 |
| 43 | MP0000566_synostosis | 1.04412738 |
| 44 | MP0009384_cardiac_valve_regurgitation | 1.03199070 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 1.03066127 |
| 46 | MP0009763_increased_sensitivity_to | 1.02802867 |
| 47 | MP0005647_abnormal_sex_gland | 0.99862743 |
| 48 | MP0009053_abnormal_anal_canal | 0.99672988 |
| 49 | MP0005408_hypopigmentation | 0.99390456 |
| 50 | MP0002249_abnormal_larynx_morphology | 0.97223551 |
| 51 | MP0000751_myopathy | 0.87698681 |
| 52 | MP0001915_intracranial_hemorrhage | 0.87669196 |
| 53 | MP0005409_darkened_coat_color | 0.87471584 |
| 54 | MP0008469_abnormal_protein_level | 0.85369104 |
| 55 | MP0002060_abnormal_skin_morphology | 0.83754841 |
| 56 | MP0010234_abnormal_vibrissa_follicle | 0.81436514 |
| 57 | MP0002295_abnormal_pulmonary_circulatio | 0.80748437 |
| 58 | MP0000858_altered_metastatic_potential | 0.79946017 |
| 59 | MP0003300_gastrointestinal_ulcer | 0.79809993 |
| 60 | MP0005023_abnormal_wound_healing | 0.79325302 |
| 61 | MP0003724_increased_susceptibility_to | 0.79226263 |
| 62 | MP0003690_abnormal_glial_cell | 0.78620648 |
| 63 | MP0005165_increased_susceptibility_to | 0.77039465 |
| 64 | MP0005636_abnormal_mineral_homeostasis | 0.76751335 |
| 65 | MP0003279_aneurysm | 0.76029783 |
| 66 | MP0008004_abnormal_stomach_pH | 0.75653480 |
| 67 | MP0005084_abnormal_gallbladder_morpholo | 0.75635637 |
| 68 | MP0009642_abnormal_blood_homeostasis | 0.75630917 |
| 69 | MP0000003_abnormal_adipose_tissue | 0.74480737 |
| 70 | MP0005623_abnormal_meninges_morphology | 0.74176879 |
| 71 | MP0001756_abnormal_urination | 0.73878556 |
| 72 | MP0004130_abnormal_muscle_cell | 0.72656634 |
| 73 | MP0005670_abnormal_white_adipose | 0.71997885 |
| 74 | MP0005376_homeostasis/metabolism_phenot | 0.71828066 |
| 75 | MP0001849_ear_inflammation | 0.71567350 |
| 76 | MP0003091_abnormal_cell_migration | 0.70114962 |
| 77 | MP0003453_abnormal_keratinocyte_physiol | 0.69985598 |
| 78 | MP0006138_congestive_heart_failure | 0.69622497 |
| 79 | MP0009765_abnormal_xenobiotic_induced | 0.67999641 |
| 80 | MP0003172_abnormal_lysosome_physiology | 0.67682867 |
| 81 | MP0003329_amyloid_beta_deposits | 0.67454562 |
| 82 | MP0003436_decreased_susceptibility_to | 0.66813379 |
| 83 | MP0002168_other_aberrant_phenotype | 0.66811208 |
| 84 | MP0000678_abnormal_parathyroid_gland | 0.65737002 |
| 85 | MP0002896_abnormal_bone_mineralization | 0.65633593 |
| 86 | MP0002971_abnormal_brown_adipose | 0.64998924 |
| 87 | MP0005220_abnormal_exocrine_pancreas | 0.64705821 |
| 88 | MP0002136_abnormal_kidney_physiology | 0.62565158 |
| 89 | MP0005076_abnormal_cell_differentiation | 0.61500436 |
| 90 | MP0005164_abnormal_response_to | 0.61366532 |
| 91 | MP0003959_abnormal_lean_body | 0.61356225 |
| 92 | MP0002970_abnormal_white_adipose | 0.60730647 |
| 93 | MP0005334_abnormal_fat_pad | 0.60681517 |
| 94 | MP0002928_abnormal_bile_duct | 0.60271956 |
| 95 | MP0005257_abnormal_intraocular_pressure | 0.59627091 |
| 96 | MP0002078_abnormal_glucose_homeostasis | 0.58792519 |
| 97 | MP0000343_altered_response_to | 0.57993990 |
| 98 | MP0003566_abnormal_cell_adhesion | 0.57089507 |
| 99 | MP0008874_decreased_physiological_sensi | 0.55848230 |
| 100 | MP0004782_abnormal_surfactant_physiolog | 0.55131769 |
| 101 | MP0006082_CNS_inflammation | 0.55047290 |
| 102 | MP0003075_altered_response_to | 0.54746906 |
| 103 | MP0004883_abnormal_blood_vessel | 0.54086185 |
| 104 | MP0005464_abnormal_platelet_physiology | 0.53190309 |
| 105 | MP0002796_impaired_skin_barrier | 0.53176669 |
| 106 | MP0005166_decreased_susceptibility_to | 0.52966776 |
| 107 | MP0001243_abnormal_dermal_layer | 0.52129612 |
| 108 | MP0000639_abnormal_adrenal_gland | 0.51909829 |
| 109 | MP0005248_abnormal_Harderian_gland | 0.51629941 |
| 110 | MP0000249_abnormal_blood_vessel | 0.50680042 |
| 111 | MP0005395_other_phenotype | 0.50339487 |
| 112 | MP0005058_abnormal_lysosome_morphology | 0.48757195 |
| 113 | MP0002876_abnormal_thyroid_physiology | 0.47674230 |
| 114 | MP0002090_abnormal_vision | 0.47423432 |
| 115 | MP0001661_extended_life_span | 0.46020269 |
| 116 | MP0004947_skin_inflammation | 0.45789369 |
| 117 | MP0004272_abnormal_basement_membrane | 0.45425943 |
| 118 | MP0005266_abnormal_metabolism | 0.45302948 |
| 119 | MP0009115_abnormal_fat_cell | 0.44640520 |
| 120 | MP0001958_emphysema | 0.44066152 |
| 121 | MP0001533_abnormal_skeleton_physiology | 0.42454235 |
| 122 | MP0005666_abnormal_adipose_tissue | 0.42154247 |
| 123 | MP0005535_abnormal_body_temperature | 0.41982171 |
| 124 | MP0003638_abnormal_response/metabolism_ | 0.40527063 |
| 125 | MP0005503_abnormal_tendon_morphology | 0.40352922 |
| 126 | MP0005448_abnormal_energy_balance | 0.40047452 |
| 127 | MP0001881_abnormal_mammary_gland | 0.39527210 |
| 128 | MP0008873_increased_physiological_sensi | 0.38915916 |
| 129 | MP0002135_abnormal_kidney_morphology | 0.38430873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.34287528 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.69904342 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.53854643 |
| 4 | Xanthomatosis (HP:0000991) | 6.15485963 |
| 5 | * Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.93683233 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.82216654 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.77136897 |
| 8 | Complement deficiency (HP:0004431) | 5.31634879 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.15690265 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.53419144 |
| 11 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.50655932 |
| 12 | Epidermoid cyst (HP:0200040) | 4.35451447 |
| 13 | Joint hemorrhage (HP:0005261) | 4.30773829 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.21935604 |
| 15 | Hyperammonemia (HP:0001987) | 4.16488969 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.16426271 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.14815253 |
| 18 | Abnormality of complement system (HP:0005339) | 4.03076201 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.02077652 |
| 20 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.75561660 |
| 21 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.75561660 |
| 22 | Ketosis (HP:0001946) | 3.75281455 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.75076756 |
| 24 | Hyperglycinemia (HP:0002154) | 3.71344234 |
| 25 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.70028910 |
| 26 | * Fat malabsorption (HP:0002630) | 3.63357776 |
| 27 | Abnormality of methionine metabolism (HP:0010901) | 3.62207284 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 3.58899986 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.55649357 |
| 30 | Abnormal ciliary motility (HP:0012262) | 3.55319111 |
| 31 | Rhinitis (HP:0012384) | 3.53450711 |
| 32 | Hypoglycemic coma (HP:0001325) | 3.53393690 |
| 33 | Hyperglycinuria (HP:0003108) | 3.50844182 |
| 34 | Absent/shortened dynein arms (HP:0200106) | 3.48064593 |
| 35 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.48064593 |
| 36 | Myocardial infarction (HP:0001658) | 3.47660780 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.45243355 |
| 38 | Abnormality of glycine metabolism (HP:0010895) | 3.45243355 |
| 39 | Hypercholesterolemia (HP:0003124) | 3.40267026 |
| 40 | Conjugated hyperbilirubinemia (HP:0002908) | 3.18698128 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.12242826 |
| 42 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.08012704 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 3.02377087 |
| 44 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.96629015 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.94164420 |
| 46 | Nasal polyposis (HP:0100582) | 2.89287438 |
| 47 | Chronic bronchitis (HP:0004469) | 2.88708428 |
| 48 | Mitral stenosis (HP:0001718) | 2.87186548 |
| 49 | Hyperbilirubinemia (HP:0002904) | 2.86552701 |
| 50 | Skin nodule (HP:0200036) | 2.78820015 |
| 51 | Abnormality of the nasal mucosa (HP:0000433) | 2.77030523 |
| 52 | Abnormality of nucleobase metabolism (HP:0010932) | 2.73974320 |
| 53 | Vascular calcification (HP:0004934) | 2.73737322 |
| 54 | Ketoacidosis (HP:0001993) | 2.72655898 |
| 55 | Cardiovascular calcification (HP:0011915) | 2.67342012 |
| 56 | Delayed CNS myelination (HP:0002188) | 2.63047121 |
| 57 | Esophageal varix (HP:0002040) | 2.61563143 |
| 58 | Spastic diplegia (HP:0001264) | 2.60255965 |
| 59 | Purpura (HP:0000979) | 2.59082768 |
| 60 | Abnormality of purine metabolism (HP:0004352) | 2.56955128 |
| 61 | Spontaneous abortion (HP:0005268) | 2.56291430 |
| 62 | * Steatorrhea (HP:0002570) | 2.56124679 |
| 63 | Abnormality of serum amino acid levels (HP:0003112) | 2.51377133 |
| 64 | Glomerulonephritis (HP:0000099) | 2.49643455 |
| 65 | Amyloidosis (HP:0011034) | 2.38894209 |
| 66 | Vertebral compression fractures (HP:0002953) | 2.36704117 |
| 67 | Metabolic acidosis (HP:0001942) | 2.36269230 |
| 68 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.33264851 |
| 69 | Neonatal onset (HP:0003623) | 2.32092065 |
| 70 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.30923314 |
| 71 | Mucopolysacchariduria (HP:0008155) | 2.30923314 |
| 72 | Bronchiectasis (HP:0002110) | 2.30838220 |
| 73 | Gout (HP:0001997) | 2.29952148 |
| 74 | Abnormal gallbladder morphology (HP:0012437) | 2.29850854 |
| 75 | Neurofibrillary tangles (HP:0002185) | 2.29695156 |
| 76 | Abnormal gallbladder physiology (HP:0012438) | 2.28899291 |
| 77 | Cholecystitis (HP:0001082) | 2.28899291 |
| 78 | Cholelithiasis (HP:0001081) | 2.27170774 |
| 79 | Hypochromic microcytic anemia (HP:0004840) | 2.26374740 |
| 80 | Nephritis (HP:0000123) | 2.26078742 |
| 81 | Hemorrhage of the eye (HP:0011885) | 2.25343780 |
| 82 | Malnutrition (HP:0004395) | 2.24322954 |
| 83 | Abnormal cartilage morphology (HP:0002763) | 2.23961538 |
| 84 | Peritonitis (HP:0002586) | 2.19288025 |
| 85 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.18303480 |
| 86 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.18303480 |
| 87 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.18303480 |
| 88 | Dicarboxylic aciduria (HP:0003215) | 2.16448507 |
| 89 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.16448507 |
| 90 | Hydroxyprolinuria (HP:0003080) | 2.12391497 |
| 91 | Abnormality of proline metabolism (HP:0010907) | 2.12391497 |
| 92 | Lethargy (HP:0001254) | 2.12092963 |
| 93 | Sensorimotor neuropathy (HP:0007141) | 2.10756691 |
| 94 | Gingival bleeding (HP:0000225) | 2.08821908 |
| 95 | Cerebral inclusion bodies (HP:0100314) | 2.08318020 |
| 96 | Acanthocytosis (HP:0001927) | 2.06018639 |
| 97 | Hypoglycemic seizures (HP:0002173) | 2.03414779 |
| 98 | Protrusio acetabuli (HP:0003179) | 2.03309140 |
| 99 | Irritability (HP:0000737) | 2.02388198 |
| 100 | Menorrhagia (HP:0000132) | 1.99448158 |
| 101 | Polycythemia (HP:0001901) | 1.97850747 |
| 102 | Obstructive sleep apnea (HP:0002870) | 1.96513616 |
| 103 | Pancreatitis (HP:0001733) | 1.95130003 |
| 104 | Opisthotonus (HP:0002179) | 1.93477746 |
| 105 | Atelectasis (HP:0100750) | 1.92361877 |
| 106 | Dysostosis multiplex (HP:0000943) | 1.91590520 |
| 107 | Thrombophlebitis (HP:0004418) | 1.89085135 |
| 108 | Abnormality of iron homeostasis (HP:0011031) | 1.87955953 |
| 109 | Abnormality of the gallbladder (HP:0005264) | 1.87669593 |
| 110 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86767158 |
| 111 | Hypophosphatemic rickets (HP:0004912) | 1.83070158 |
| 112 | Nuclear cataract (HP:0100018) | 1.83035849 |
| 113 | Distal lower limb muscle weakness (HP:0009053) | 1.82799007 |
| 114 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82243858 |
| 115 | Atrioventricular block (HP:0001678) | 1.82123570 |
| 116 | Late onset (HP:0003584) | 1.81437586 |
| 117 | Flat acetabular roof (HP:0003180) | 1.80659177 |
| 118 | Turricephaly (HP:0000262) | 1.79377344 |
| 119 | * Rickets (HP:0002748) | 1.78701590 |
| 120 | Back pain (HP:0003418) | 1.78683881 |
| 121 | Cervical subluxation (HP:0003308) | 1.78384433 |
| 122 | Generalized aminoaciduria (HP:0002909) | 1.78074275 |
| 123 | Abnormality of carpal bone ossification (HP:0006257) | 1.77386968 |
| 124 | Abnormality of the Achilles tendon (HP:0005109) | 1.76626959 |
| 125 | Vomiting (HP:0002013) | 1.76316424 |
| 126 | Stroke (HP:0001297) | 1.76245942 |
| 127 | Increased mean platelet volume (HP:0011877) | 1.76241083 |
| 128 | Male infertility (HP:0003251) | 1.73970472 |
| 129 | Right ventricular cardiomyopathy (HP:0011663) | 1.73149965 |
| 130 | Infertility (HP:0000789) | 1.73019804 |
| 131 | Ectopia lentis (HP:0001083) | 1.71774990 |
| 132 | Achilles tendon contracture (HP:0001771) | 1.70438914 |
| 133 | Hypertriglyceridemia (HP:0002155) | 1.70325054 |
| 134 | Premature rupture of membranes (HP:0001788) | 1.68932665 |
| 135 | Abnormality of glycolipid metabolism (HP:0010969) | 1.68387317 |
| 136 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.68387317 |
| 137 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.68387317 |
| 138 | Elevated alkaline phosphatase (HP:0003155) | 1.68307158 |
| 139 | Recurrent otitis media (HP:0000403) | 1.66669232 |
| 140 | Polygenic inheritance (HP:0010982) | 1.64437412 |
| 141 | Short nail (HP:0001799) | 1.63889735 |
| 142 | Interstitial pulmonary disease (HP:0006530) | 1.62761038 |
| 143 | Increased serum ferritin (HP:0003281) | 1.62752547 |
| 144 | Neonatal hypoglycemia (HP:0001998) | 1.60436566 |
| 145 | Renal salt wasting (HP:0000127) | 1.58510113 |
| 146 | Acanthosis nigricans (HP:0000956) | 1.58107550 |
| 147 | Vascular tortuosity (HP:0004948) | 1.54517451 |
| 148 | Upper limb amyotrophy (HP:0009129) | 1.53405070 |
| 149 | Distal upper limb amyotrophy (HP:0007149) | 1.53405070 |
| 150 | Osteomalacia (HP:0002749) | 1.53064036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.56140366 |
| 2 | ERN1 | 4.46093510 |
| 3 | FGFR4 | 4.04707986 |
| 4 | SIK1 | 4.00205102 |
| 5 | TRIB3 | 2.76121858 |
| 6 | ICK | 2.71624409 |
| 7 | SMG1 | 2.40413668 |
| 8 | PKN2 | 2.33311477 |
| 9 | ERBB4 | 2.26835243 |
| 10 | EEF2K | 2.19342846 |
| 11 | PRPF4B | 2.10629105 |
| 12 | MST1R | 2.10406463 |
| 13 | LATS1 | 2.02299128 |
| 14 | IRAK3 | 1.94275977 |
| 15 | TESK1 | 1.85838712 |
| 16 | PRKD3 | 1.78816756 |
| 17 | EPHA3 | 1.73579608 |
| 18 | FRK | 1.73522277 |
| 19 | RIPK1 | 1.73487474 |
| 20 | MAPKAPK3 | 1.73237738 |
| 21 | EPHB1 | 1.66107559 |
| 22 | MAP3K3 | 1.64100428 |
| 23 | PTK6 | 1.63492829 |
| 24 | INSRR | 1.57102726 |
| 25 | NEK9 | 1.56557655 |
| 26 | KDR | 1.50105633 |
| 27 | TAOK3 | 1.50050973 |
| 28 | EPHB2 | 1.49775450 |
| 29 | TYK2 | 1.49771983 |
| 30 | TBK1 | 1.45167688 |
| 31 | MAP2K3 | 1.44611485 |
| 32 | JAK1 | 1.41682409 |
| 33 | TGFBR2 | 1.36284804 |
| 34 | PIK3CG | 1.30343546 |
| 35 | TTN | 1.23655397 |
| 36 | FGFR2 | 1.22816581 |
| 37 | MAP2K4 | 1.21884378 |
| 38 | CDC42BPA | 1.20052906 |
| 39 | MAP3K14 | 1.17313759 |
| 40 | EPHA2 | 1.16842199 |
| 41 | LMTK2 | 1.16143036 |
| 42 | MAPK11 | 1.11151833 |
| 43 | FLT3 | 1.11111286 |
| 44 | PDGFRA | 1.10880970 |
| 45 | CDK12 | 1.05366983 |
| 46 | ABL2 | 1.05282636 |
| 47 | AKT3 | 1.02995821 |
| 48 | MARK2 | 1.02786539 |
| 49 | NTRK1 | 1.02224802 |
| 50 | DYRK1B | 1.02120033 |
| 51 | STK38 | 1.01673106 |
| 52 | PAK4 | 1.01532729 |
| 53 | ARAF | 1.00926668 |
| 54 | PTK2 | 0.99827581 |
| 55 | FER | 0.99406229 |
| 56 | TIE1 | 0.98159450 |
| 57 | CDK6 | 0.98000234 |
| 58 | MET | 0.97854980 |
| 59 | JAK2 | 0.97139299 |
| 60 | PAK3 | 0.95925567 |
| 61 | FGFR3 | 0.91133728 |
| 62 | IKBKE | 0.89483346 |
| 63 | MAPK15 | 0.89161595 |
| 64 | CAMK1G | 0.87274047 |
| 65 | MAP3K7 | 0.87112410 |
| 66 | MAP2K1 | 0.85891812 |
| 67 | DDR2 | 0.85776388 |
| 68 | LRRK2 | 0.85191240 |
| 69 | BMX | 0.83312797 |
| 70 | MAP3K13 | 0.82865441 |
| 71 | PRKD2 | 0.80071839 |
| 72 | ERBB2 | 0.78894039 |
| 73 | DAPK2 | 0.77099830 |
| 74 | MAP3K6 | 0.74756599 |
| 75 | CSK | 0.74484638 |
| 76 | MAP3K11 | 0.71167923 |
| 77 | STK38L | 0.71028948 |
| 78 | MYLK | 0.70053810 |
| 79 | GSK3A | 0.69026994 |
| 80 | KSR2 | 0.68657300 |
| 81 | LATS2 | 0.68565191 |
| 82 | TAOK1 | 0.67146928 |
| 83 | MAP3K2 | 0.66984617 |
| 84 | CAMKK1 | 0.65285236 |
| 85 | MAPK12 | 0.63332345 |
| 86 | PRKAA2 | 0.61801521 |
| 87 | GRK6 | 0.60952339 |
| 88 | RET | 0.60199860 |
| 89 | PDK2 | 0.59903334 |
| 90 | RPS6KA4 | 0.59766687 |
| 91 | PIM2 | 0.59275529 |
| 92 | CHUK | 0.59005828 |
| 93 | PRKCZ | 0.58890380 |
| 94 | FGFR1 | 0.58279568 |
| 95 | PDK1 | 0.57597546 |
| 96 | MAP2K2 | 0.55334497 |
| 97 | ZAP70 | 0.54440092 |
| 98 | PAK2 | 0.54095132 |
| 99 | RPS6KA2 | 0.53047383 |
| 100 | CAMK1D | 0.52855070 |
| 101 | MTOR | 0.52771479 |
| 102 | HIPK2 | 0.51376598 |
| 103 | IGF1R | 0.51207939 |
| 104 | MAPK4 | 0.49399786 |
| 105 | MAP3K10 | 0.48559748 |
| 106 | CAMK2G | 0.47504783 |
| 107 | MAP2K6 | 0.46524724 |
| 108 | IKBKB | 0.45815394 |
| 109 | JAK3 | 0.45464199 |
| 110 | PRKAA1 | 0.45017736 |
| 111 | PDK3 | 0.44770189 |
| 112 | PDK4 | 0.44770189 |
| 113 | SCYL2 | 0.44294791 |
| 114 | PRKCH | 0.42945069 |
| 115 | PRKD1 | 0.42347075 |
| 116 | PINK1 | 0.41505258 |
| 117 | AKT2 | 0.41315387 |
| 118 | PDPK1 | 0.41014079 |
| 119 | NLK | 0.40996705 |
| 120 | PBK | 0.40804497 |
| 121 | SGK3 | 0.40648642 |
| 122 | MAPK7 | 0.40506930 |
| 123 | MAP3K1 | 0.39647186 |
| 124 | PDGFRB | 0.39583816 |
| 125 | EGFR | 0.39398289 |
| 126 | TRPM7 | 0.39138158 |
| 127 | PIK3CA | 0.38299225 |
| 128 | PRKACG | 0.38248341 |
| 129 | STK3 | 0.38112699 |
| 130 | ABL1 | 0.37939824 |
| 131 | TAOK2 | 0.37773924 |
| 132 | CDK9 | 0.36902400 |
| 133 | NEK6 | 0.35291770 |
| 134 | SRC | 0.33230703 |
| 135 | LIMK1 | 0.31182666 |
| 136 | ILK | 0.29700835 |
| 137 | NTRK3 | 0.27851761 |
| 138 | MELK | 0.26386365 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.32671150 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.58248951 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.32896786 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.03477317 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.78795718 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.75379228 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63493121 |
| 8 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.62015842 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.59686557 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.58409063 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51070731 |
| 12 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.34267943 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.33728227 |
| 14 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.29790477 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.27408161 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.24322449 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.11118304 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.95040310 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.93556227 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.93489056 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.92918600 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86155800 |
| 23 | Retinol metabolism_Homo sapiens_hsa00830 | 1.81402837 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80894261 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.77360465 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.75878193 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68901333 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.66750653 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54051719 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.51332961 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.49287368 |
| 32 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46635270 |
| 33 | * Bile secretion_Homo sapiens_hsa04976 | 1.43913412 |
| 34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42347072 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41369890 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39267964 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.39194718 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.32948456 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25644878 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23564889 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.17880199 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14755768 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12675428 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.10609584 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08840461 |
| 46 | Sulfur relay system_Homo sapiens_hsa04122 | 1.02097487 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.00498913 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.00319158 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99240312 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98956195 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.97904074 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97340132 |
| 53 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.85756344 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.85244927 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84588806 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84039928 |
| 57 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82158165 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.81559742 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80281768 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.77392532 |
| 61 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70546791 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69094593 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.68662080 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64196849 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59399076 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52645736 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.51931278 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.41863441 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40574717 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37773290 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.34855954 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33670184 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32062161 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.29479873 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27131827 |
| 76 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.23757818 |
| 77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.17263055 |
| 78 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.15824812 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.11747936 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.10726179 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.09454524 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.09074586 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.07960437 |
| 84 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.07940858 |
| 85 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.07265599 |
| 86 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.06329905 |
| 87 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.05225509 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.05217151 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.05214493 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.04487820 |
| 91 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.03586717 |
| 92 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02494720 |
| 93 | Malaria_Homo sapiens_hsa05144 | 0.01775451 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.01753036 |
| 95 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.01585663 |
| 96 | Tight junction_Homo sapiens_hsa04530 | 0.01213137 |
| 97 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.00898443 |
| 98 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1431100 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | -0.1392480 |
| 100 | Focal adhesion_Homo sapiens_hsa04510 | -0.1346899 |
| 101 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1126297 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1119605 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | -0.1117057 |
| 104 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1061695 |
| 105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0938636 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0858501 |
| 107 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0829382 |
| 108 | Lysosome_Homo sapiens_hsa04142 | -0.0679727 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0509619 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | -0.0336562 |
| 111 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0274581 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0049983 |
| 113 | Pertussis_Homo sapiens_hsa05133 | -0.0003978 |

